Biomarker Technologies Market Research Report 2022, Industry Trends, Share, Size, Demand and Future Scope 2027

IMARC Group's latest report, titled "Biomarker Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", the global biomarker technologies market size reached US$ 31.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 67.7 Billion by 2027, exhibiting a growth rate (CAGR) of 13.71% during 2022-2027.

Biomarker technologies are measurable indicators of a biological condition or state. They are cost-effective and reliable detection tools that heavily rely on genetic biomarkers, including ribonucleic acid (RNA) and deoxyribonucleic acid (DNA), to detect pathogens. A biomarker is injected into an organism to analyze the appropriate functioning of any organ that assist in the early diagnosis of various diseases and disorders, along with drug discovery and development processes to understand fundamental biological relationships. Additionally, they are also utilized in the treatment of cardiovascular diseases, immunological and genetic disorders, cancer, nervous system disorders, and infections and help in making clinical decision-making. Some of the commonly used biomarker technologies include next-generation sequencing (NGS), immunoassay, and polymerase chain reaction (PCR).

Competitive Landscape with Key Players:

The competitive landscape of the industry has also been examined along with the profiles of the key players being

• Agilent Technologies Inc
• Bio-Rad Laboratories Inc
• Danaher Corporation
• F. Hoffmann-La Roche AG
• Illumina Inc
• LI-COR Inc
• Merck KGaA
• PerkinElmer Inc
• QIAGEN N.V
• Shimadzu Corporation
• Thermo Fisher Scientific Inc
• Waters Corporation

Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/biomarker-technologies-market/requestsample

Biomarker Technologies Market Trends:

The escalating prevalence of numerous chronic diseases majorly drives the global market. This can be attributed to the increasing population suffering from cancer due to the sedentary lifestyle led by the masses. Coupled with this, the accelerating need for early and effective diagnosis across the healthcare sector is positively influencing the demand for biomarker technologies across the globe. Apart from this, extensive research and development (R&D) activities conducted in the field of life science are catalyzing the market.

Moreover, continual technological advancements in biomarkers, such as the introduction of biomarker signatures that assist in the easy treatment of neurological diseases, are creating a positive market outlook. Some of the other factors driving the market include the integration of artificial intelligence (AI), and machine learning (ML) solutions with digital biomarkers, and numerous investments to upgrade the overall healthcare infrastructure.

Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/biomarker-technologies-market

Key Market Segmentation:

Breakup by Test Type:

• Solid Biopsy
• Liquid Biopsy

Breakup by Indication:

• Cancer
• Infectious Diseases
• Autoimmune Disorders
• Cardiovascular Disorders
• Others

Breakup by Product:

• Consumables
• Assay
• Reagent
• Instruments

Breakup by Technology:

• Polymerase Chain Reaction (PCR)
• Next Generation Sequencing (NGS)
• Immunoassay
• Others

Breakup by Application:

• Drug Discovery
• Clinical Diagnostics
• Personalized Medicine

Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report:

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Browse More Research Reports:

• https://www.imarcgroup.com/carbon-capture-storage-market
• https://www.imarcgroup.com/smart-inhalers-market
• https://www.imarcgroup.com/3d-scanning-market
• https://www.imarcgroup.com/healthcare-predictive-analytics-market
• https://www.imarcgroup.com/energy-storage-systems-market

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.